ABBEY MCMURRAY: Open Payments
NPI 1760064505 · PORT ORANGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 34 payments from 13 companies in 2025. Trend: 2023 $1,057 · 2024 $784 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 6 | $139 |
| Janssen Biotech, Inc. | 9 | $137 |
| GENZYME CORPORATION | 5 | $119 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| PFIZER INC. | 2 | $42 |
| Galderma Laboratories, L.P. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Biofrontera Inc. | 1 | $21 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
Products named: DUPIXENT, ADBRY, TREMFYA, LITFULO, NEMLUVIO, COSENTYX, Rhapsido, ILUMYA.
Industry payments across FL — which companies pay providers there.
